Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan-Feb;96(1):67-76.
doi: 10.5740/jaoacint.12-280.

Method development and validation for ultra-high pressure liquid chromatography/tandem mass spectrometry determination of multiple prostanoids in biological samples

Affiliations

Method development and validation for ultra-high pressure liquid chromatography/tandem mass spectrometry determination of multiple prostanoids in biological samples

Rui Yu et al. J AOAC Int. 2013 Jan-Feb.

Abstract

Following oxygenation of arachidonic acid by cyclooxygenase to form prostaglandin H2 (PGH2), a variety of prostanoids can be generated with diverse physiologic effects on pain, inflammation, allergy, cardiovascular system, cancer, etc. To facilitate the quantitative analysis of prostanoids in human serum of cell culture, an ultra-high pressure LC (UHPLC)/MS/MS method was developed and validated for the measurement of six eicosanoids belonging to the cyclooxygenase pathway: PGE2, PGD2, 8-iso-PGF2alpha, PGF2alpha, 6-keto-PGF1alpha, and thromboxane B2 (TXB2). Selectivity, matrix effects, calibration model, precision, and accuracy (intraday and interday), lower limit of quantitation (LLOQ), recovery, stability, and sample dilution were evaluated. Fast UHPLC separation was carried out in only 0.5 min with isocratic elution, and each prostanoid was measured using negative electrospray ionization MS with collision-induced dissociation and selected reaction monitoring. UHPLC/MS/MS provided high throughput with peak widths of approximately 3 s and an LLOQ of 0.020 ng/mL for PGE2, 0.027 ng/mL for PGD2, 0.152 ng/mL for 8-iso-PGF2alpha, 0.179 ng/mL for PGF2alpha and 6-keto-PGF1alpha, and 0.013 ng/mL for TXB2.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chemical structures of PGE2, PGD2, PGF, 8-iso-PGF, 6-keto-PGF, and TXB2.
Figure 2
Figure 2
Negative ESI UHPLC/MS/MS SRM chromatograms of PGE2, PGD2, 8-iso-PGF, PGF, 6-keto-PGF, and TXB2 (1 ng/mL each) and internal standards d4-PGE2, and d4-PGD2 (20 ng/mL each) extracted from DMEM containing 10% pooled blank human serum.
Figure 3
Figure 3
Negative ESI UHPLC/MS/MS SRM chromatograms of (A) PGE2 and PGD2 (0.05 ng/mL), (B) 8-iso-PGF and PGF (0.5 ng/mL), (C) 6-keto-PGF (0.5 ng/mL), and (D) TXB2 (0.05 ng/mL) extracted from DMEM containing 10% pooled blank human serum.
Figure 4
Figure 4
Negative ESI UHPLC/MS/MS SRM chromatograms of PGE2, PGD2, 8-iso-PGF, PGF, 6-keto-PGF, and TXB2, d4-PGE2, and d4-PGD2 extracted from BMDM cell culture. Note that 8-iso-PGF, PGF, or 6-keto-PGF was not detected in these cells (see chromatograms for the SRM transitions of m/z 353 to m/z 193 and m/z 369 to m/z 163, respectively).

Similar articles

Cited by

References

    1. Nicolaou A. In: Bioactive Lipids. Nicolaou A, Kokotos G, editors. Oily Press; Bridgwater, UK: 2004. pp. 197–222.
    1. Yu R, Xiao L, Zhao G, Christman JW, van Breemen RB. J Pharmacol Exp Ther. 2011;339:716–725. http://dx.doi.org/10.1124/jpet.111.185405. - DOI - PMC - PubMed
    1. Smyth EM, Grosser T, Wang M, Yu Y, FitzGerald GA. J Lipid Res. 2009:S423–S428. - PMC - PubMed
    1. McAdam BF, Catella-Lawson F, Mardini IA, Kapoor S, Lawson JA, FitzGerald GA. Proc Natl Acad Sci USA. 1999;96:272–277. http://dx.doi.org/10.1073/pnas.96.1.272. - DOI - PMC - PubMed
    1. Bhagwat SS, Hamann PR, Still WC, Bunting S, Fitzpatrick FA. Nature. 1985;315:511–513. http://dx.doi.org/10.1038/315511a0. - DOI - PubMed

Publication types

LinkOut - more resources